版权说明 操作指南
首页 > 成果 > 详情

Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: Role of ATGL and HSL

认领
导出
下载 Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Wang, Ping-Ping;She, Mei-Hua;He, Ping -Ping;Chen, Wu-Jun;Laudon, Moshe;...
通讯作者:
Yin, Wei-Dong
作者机构:
[Xu, Xuan-Xuan; He, Ping -Ping; Yin, Wei-Dong; Chen, Wu-Jun; Wang, Ping-Ping] Univ South China, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China.
[Yin, Wei-Dong; She, Mei-Hua] Univ South China, Dept Biochem & Mol Biol, Sch Life Sci & Technol, Hengyang 421001, Hunan, Peoples R China.
[Chen, Wu-Jun] Univ South China, Inst Pharm, Hengyang 421001, Hunan, Peoples R China.
[Chen, Wu-Jun] Univ South China, Inst Pharmacol, Hengyang 421001, Hunan, Peoples R China.
[Laudon, Moshe] Neurim Pharmaceut Ltd, Drug Discovery, Tel Aviv, Israel.
通讯机构:
[Yin, Wei-Dong] U
Univ South China, Inst Cardiovasc Res, Hengyang 421001, Hunan, Peoples R China.
语种:
英文
关键词:
3T3-L1 adipocyte;ATGL HSL;Ca2+;Insulin resistance;Piromelatine;Triglyceride
期刊:
Biochimie
ISSN:
0300-9084
年:
2013
卷:
95
期:
8
页码:
1650-1654
基金类别:
The authors gratefully acknowledge the financial support from the National Natural Sciences Foundation of China ( 81270296 and 81200590 ).
机构署名:
本校为第一且通讯机构
院系归属:
化学化工学院
医学院
药学与生物科学学院
摘要:
Piromelatine, a novel investigational multimodal sleep medicine, is developed for the treatment of patients with primary and co-morbid insomnia. Piromelatine has been shown to inhibit weight gain and improve insulin sensitivity in high-fat/high-sucrose-fed (HFHS) rats. Considering that piromelatine has also been implicated in lowering of triglyceride levels in HFHS rats, this work elucidated whether this effect involves in the regulation of adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) in triglyceride (TG) metabolism. In...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com